The latest company news from NHS Supply Chain

Company news

Health and Care Innovation Expo 2017

Thursday 7 September 2017


The High Cost Tariff-Excluded Devices (HCTED) programme is hosting two panel discussions at NHS England’s Health & Care Expo in Manchester. Both sessions are on day two (12 September) and cover different aspects of improving patient care through innovating procurement.


‘Transforming Procurement – Patients, Price, Purchasing’

12/09/2017, 09:00-10:00 in Theatre 1

Run by NHS England National Specialised Commissioning, the session will focus on getting the balance right between offering more patients rapid access to innovative treatments, whilst staying on a tight budget.

The session will consider how NHS England is modernising procurement to afford innovative technology. What treatments/devices should the NHS afford; how can it speed the process up? How does NHS England choose which innovative technology to provide to optimise patient outcomes; who makes those decisions and are they the right ones?

Helen Lisle, Director of Procurement at Newcastle University NHS Foundation Trust will chair the session. Mark Hart, Procurement Director, Specialist Categories at NHS Supply Chain will be on the panel and will be joined by:

  • Dr Vaughan Lewis, Director Specialised Commissioning NHS South and Clinical Lead for HCTED
  • Mark Stevens, Head of P2P, Procurement and eCommerce Department at Central Manchester University Hospitals NHS Foundation Trust
  • Howard Blackith, Programme Director, Procurement Transformation Programme, Department of Health

Dr Vaughan Lewis: “This discussion gives us a chance to shed some light on the task of rationalising the catalogue of clinical supplies. I know the list for some device types is extensive – with little focus on the HCTEDs.

The annual spend on these devices across all providers exceeds £500 million. Historically there have been wide variations in the prices that individual Trusts have paid for the same products. It is estimated that over time, the transition to a single supply chain could generate efficiency savings of around 10% of the total spend.”


‘Affording Innovation? – Understanding NHS England’s High Cost Tariff-Excluded Devices Programme’

12/09/2017, 12:00-12:45 Pop-up University 8

Ever wondered how NHS England selects the medical devices that cost the most money and are therefore excluded from tariff? A deep-dive panel discussion with the specialised commissioning team will explore how NHS England makes these tough decisions whilst ensuring appropriate access for patients.

There will be a focus on ground-breaking initiatives aligned with Lord Carter’s review to centralise the procurement of high-cost tariff-excluded devices (HCTEDs). The session will introduce the approach being taken by NHS England to rationalise the current HCTED catalogue without impacting clinical practice as well as a model for collaboration with industry to streamline the adoption of innovative new products.

NHS Supply Chain’s Phil Lewis, Head of Musculoskeletal and Cardiovascular and Procurement Advisor for HCTED will be on the panel. He will be joined by:

  • Victoria Barrie, NHS England, National Head of Contracting, Specialised Commissioning and Senior Responsible Officer for HCTED Devices Phase 1
  • Justine Stalker-Booth, NHS England, Associate Director for Specialised Commissioning Finance
  • Dr Vaughan Lewis, NHS England South Region Medical Director and Clinical Lead for HCTED

Register here for NHS England’s Health & Care Expo. Bookings for both sessions are open.

Delivering value to the NHS